Sort
40,608 grants matching “prostate cancer”
Discovery of Novel Selective Androgen Receptor Degraders (SARDs) for the Treatment of Spinobulbar Muscular Atrophy (SBMA) or Kennedyâs Disease
$380,249Ramesh Narayanan · University Of Tennessee Health Sci Ctr · R01 · FY2024 · NS
High resolution volumetric MRI for prostate cancer active surveillance
$380,240Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2021 · CA
High resolution volumetric MRI for prostate cancer active surveillance
$380,240Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Inhibitors of protein-protein interactions
$380,215Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Self-assembling protoviral nanoparticles
$380,215Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Functional characterization of prostate cancer risk loci by high throughput sequencing
$380,150Liang Wang · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Hybrid Intelligence for Trustable Diagnosis And Patient Management of Prostate Cancer (HIT-PIRADS)
$380,143Ulas Bagci · Northwestern University At Chicago · U01 · FY2025 · CA
Role of alpha6 beta1 Integrin in Prostate Cancer
$380,142Cynthia K Miranti · Van Andel Research Institute · R01 · FY2013 · CA
Project 1:
$380,083Raegan Winston Durant · University Of Alabama At Birmingham · U54 · FY2019 · CA
Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow
$380,046Michael R King · Rice University · R01 · FY2025 · CA
TOWARD UNDERSTANDING THE GENETIC PREDISPOSITION FOR SIGNALING PATHWAY ACTIVATION IN AGGRESSIVE PROSTATE CANCER
$380,010Universita' Degli Studi Di Trento · · FY2010 · Department of the Army
Elucidating a novel molecular biomarker for castration-resistant prostate cancer
$380,000Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · CA
Control of Apoptosis in Cancer by Survivin
$380,000Dario C. Altieri · Wistar Institute · R01 · FY2016 · CA
Winship Cancer Institute, Emory University
$380,000Emory University · P20 · FY2003 · CA
Control of Apoptosis in Cancer by Survivin
$380,000Dario C. Altieri · Wistar Institute · R01 · FY2017 · CA
ROLE OF COREGULATORS IN STEROID HORMONE-REGULATED TRANSCRIPTION
$379,921Michael R Stallcup · University Of Southern California · R01 · FY2013 · DK
Inhibition of CDK5 as a Treatment for Pancreatic Cancer
$379,900Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2017 · CA
Eye Disease in a Trial of Selenium and Vitamin E
$379,842William G Christen · Brigham And Women'S Hospital · R01 · FY2006 · EY
MORTALITY FOLLOW-UP AND ANALYSES OF MEN IN THE MRFIT
$379,800University Of Minnesota Twin Cities · R01 · FY2004 · HL
Postdoctoral Training Program in Cancer Epidemiology
$379,789Linda V Van Horn · Northwestern University At Chicago · R25 · FY2008 · CA
Elucidating and testing causal drivers of inflammation triggered prostatic early lesions
$379,776Angelo Michael De Marzo · Johns Hopkins University · U54 · FY2022 · CA
Molecular Epidemiology of Prostate Cancer Outcomes: Genetics, Multilevel Environ
$379,764Timothy R Rebbeck · University Of Pennsylvania · P60 · FY2016 · MD
PROTOCOL SPECIFIC RESEARCH SUPPORT
$379,737Jacqueline Lyandres · University Of California, San Francisco · P30 · FY2009 · CA
GENETIC EPIDEMIOLOGY OF PROSTATE CANCER AGGRESSIVENESS
$379,672University Of California San Francisco · R01 · FY2004 · CA
UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP
$379,635University Of Colorado Denver · U10 · FY2001 · CA